Literature DB >> 9632652

Clostridium difficile toxins A and B are cation-dependent UDP-glucose hydrolases with differing catalytic activities.

W P Ciesla1, D A Bobak.   

Abstract

Toxins A and B of Clostridium difficile are UDP-glucose glucosyltransferases that exert their cellular toxicity primarily through their abilities to monoglucosylate, and thereby inactivate, Rho family small GTPases. Toxin A also hydrolyzes UDP-glucose, although this activity is not well characterized. In this study, we measured the kinetics of UDP-glucose hydrolysis by toxins A and B and found significant differences in the catalytic activities of these two structurally homologous toxins. The toxins displayed similar Michaelis constants (Km) for UDP-glucose, but the maximal velocity (Vmax) of toxin B was approximately 5-fold greater than that of toxin A. Toxins A and B exert their enzymatic actions intracellularly, and, interestingly, we found that each toxin absolutely required K+ for optimal hydrolase activity; Na+ was inactive. The toxins also required certain divalent cations for activity and exhibited a significantly greater Vmax and lower Km in the presence of Mn2+ as compared with Mg2+. We conclude that C. difficile toxins A and B are cation-dependent UDP-glucose hydrolases that differ significantly in their catalytic activities, a finding that may have important implications in understanding their different cytotoxic effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632652     DOI: 10.1074/jbc.273.26.16021

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Clostridial toxins: molecular probes of Rho-dependent signaling and apoptosis.

Authors:  D A Bobak
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

2.  Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.

Authors:  Lea M Spyres; Jeremy Daniel; Amy Hensley; Maen Qa'Dan; William Ortiz-Leduc; Jimmy D Ballard
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

3.  Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.

Authors:  Rory N Pruitt; Nicole M Chumbler; Stacey A Rutherford; Melissa A Farrow; David B Friedman; Ben Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

Review 4.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 5.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

6.  Identification of a novel virulence factor in Clostridium difficile that modulates toxin sensitivity of cultured epithelial cells.

Authors:  Masashi Miura; Haru Kato; Osamu Matsushita
Journal:  Infect Immun       Date:  2011-07-11       Impact factor: 3.441

7.  Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B.

Authors:  Charles Darkoh; Heidi B Kaplan; Herbert L Dupont
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

8.  Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.

Authors:  Joseph W Alvin; D Borden Lacy
Journal:  J Struct Biol       Date:  2017-04-19       Impact factor: 2.867

Review 9.  A lipid-protein hybrid model for tight junction.

Authors:  David B N Lee; Nora Jamgotchian; Suni G Allen; Michael B Abeles; Harry J Ward
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-13

10.  Treatment of Clostridium difficile Infection with a Small-Molecule Inhibitor of Toxin UDP-Glucose Hydrolysis Activity.

Authors:  Ilana L Stroke; Jeffrey J Letourneau; Teresa E Miller; Yan Xu; Igor Pechik; Diana R Savoly; Linh Ma; Laurie J Sturzenbecker; Joan Sabalski; Philip D Stein; Maria L Webb; David W Hilbert
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.